A case of alpha-fetoprotein-producing esophageal adenocarcinoma
- PMID: 23347813
- PMCID: PMC11915935
- DOI: 10.1016/j.kjms.2012.08.018
A case of alpha-fetoprotein-producing esophageal adenocarcinoma
Abstract
Alpha-fetoprotein is a well-known tumor marker in the screening and follow-up of hepatocellular carcinoma. In Taiwanese society, a high prevalence of hepatitis and hepatoma and elevation of alpha-fetoprotein associated with liver function impairment usually suggested clinics undertake further examination for liver or genital tumor. We report the case of 45-year-old man who was found to have an alpha-fetoprotein-producing esophageal adenocarcinoma with an initial presentation of liver function impairment and rapid elevation of alpha-fetoprotein. Esophageal cancer was diagnosed via endoscope and a biopsy proved the presence of adenocarcinoma. A small endoscopic biopsy specimen failed to identify the alpha-fetoprotein positive tumor cell. Esophagectomy was performed and histopathological study of surgical specimen revealed grade II adenocarcinoma with regional metastatic lymphadenopathy. Immunohistochemical study was focal positive for alpha-fetoprotein. Serum alpha-fetoprotein declined transiently after esophagectomy and fluctuation of alpha-fetoprotein level was noted during the treatment with adjuvant chemotherapy. Finally, 19 months after the operation, the patient died due to multiple organ metastases with multiple organ failure. Thus, a small specimen for upper endoscopy may not be sufficient in the presence of alpha-fetoprotein-producing adenocarcinoma. Monitoring of serum alpha-fetoprotein may be useful in the evaluation and follow-up of esophageal alpha-fetoprotein-producing adenocarcinoma.
Copyright © 2012. Published by Elsevier B.V.
Figures





Similar articles
-
Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma.Clin J Gastroenterol. 2017 Feb;10(1):7-12. doi: 10.1007/s12328-016-0704-1. Epub 2016 Dec 19. Clin J Gastroenterol. 2017. PMID: 27995468 Review.
-
Alpha-fetoprotein-producing esophageal adenocarcinoma: report of a case.Surg Today. 1993;23(12):1103-7. doi: 10.1007/BF00309103. Surg Today. 1993. PMID: 7509659
-
Alpha-Fetoprotein-producing esophageal adenocarcinoma: report of a case.Surg Today. 2001;31(10):915-9. doi: 10.1007/s005950170035. Surg Today. 2001. PMID: 11759890
-
Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer.J Nippon Med Sch. 2005 Feb;72(1):66-70. doi: 10.1272/jnms.72.66. J Nippon Med Sch. 2005. PMID: 15834210
-
Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma With Enteroblastic, Yolk Sac Tumor-Like, and Hepatoid Carcinoma Differentiation: A Rare Case and Literature Review.Int J Surg Pathol. 2023 Aug;31(5):884-889. doi: 10.1177/10668969221142041. Epub 2022 Dec 13. Int J Surg Pathol. 2023. PMID: 36514283 Review.
Cited by
-
Primary adenocarcinoma of the esophagogastric junction, combined with an obscure hepatoid adenocarcinoma component, as discovered after the development of a metachronous liver metastasis.Hippokratia. 2020 Jul-Sep;24(3):138-142. Hippokratia. 2020. PMID: 34239292 Free PMC article.
-
Sustained Clinical Complete Response after Discontinuation of Trastuzumab-deruxetecan Due to Interstitial Pneumonia for HER2-positive Gastric Adenocarcinoma with Enteroblastic Differentiation (GAED).Intern Med. 2025 Jan 1;64(1):101-107. doi: 10.2169/internalmedicine.3155-23. Epub 2024 Jun 6. Intern Med. 2025. PMID: 38839335 Free PMC article.
-
The impact of inflammation and acute phase activation in cancer cachexia.Front Immunol. 2023 Oct 31;14:1207746. doi: 10.3389/fimmu.2023.1207746. eCollection 2023. Front Immunol. 2023. PMID: 38022578 Free PMC article. Review.
-
Misdiagnosis of an α-fetoprotein-producing esophageal carcinoma: A case report and literature review.Oncol Lett. 2016 Jul;12(1):597-600. doi: 10.3892/ol.2016.4664. Epub 2016 Jun 1. Oncol Lett. 2016. PMID: 27347186 Free PMC article.
-
A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy.J Gastrointest Cancer. 2019 Sep;50(3):617-620. doi: 10.1007/s12029-018-0078-3. J Gastrointest Cancer. 2019. PMID: 29457212 Free PMC article. No abstract available.
References
-
- Ciftci A.O., Bingol‐Kologlu M., Senocak M.E., Tanyel F.C., Buyukpamukcu M., Buyukpamukcu N.. Testicular tumors in children. J Pediatr Surg. 2001; 36: 1796–1801. - PubMed
-
- Huang H.Y., Ko S.F., Chuang J.H., Jeng Y.M., Sung M.T., Chen W.J.. Primary yolk sac tumor of the urachus. Arch Pathol Lab Med. 2002; 126: 1106–1109. - PubMed
-
- Lopez‐Beltran A., Luque R.J., Quintero A., Requena M.J., Montironi R.. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003; 442: 381–387. - PubMed
-
- Nakashima H., Nagafuchi K., Satoh H., Takeda K., Yamasaki T., Yonemasu H., et al. Hepatoid adenocarcinoma of the gallbladder. J Hepatobiliary Pancreat Surg. 2000; 7: 226–230. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical